| [1] |
Priftakis D, Riaz S, Zumla A, et al. Towards more accurate 18F-fluorodeoxyglucose positron emission tomography (18F-FDG PET) imaging in active and latent tuberculosis. Int J Infect Dis, 2020,92S:S85-S90. doi: 10.1016/j.ijid.2020.02.017.
doi: 10.1016/j.ijid.2020.02.017
URL
pmid: 32114199
|
| [2] |
Shah KK, Pritt BS, Alexander MP. Histopathologic review of granulomatous inflammation. J Clin Tuberc Other Mycobact Dis, 2017,7:1-12. doi: 10.1016/j.jctube.2017.02.001.
doi: 10.1016/j.jctube.2017.02.001
URL
pmid: 31723695
|
| [3] |
Chao WC, Yen CL, Wu CH, et al. How mycobacteria take advantage of the weakness in human immune system in the modern world. J Microbiol Immunol Infect, 2020,53(2):209-215. doi: 10.1016/j.jmii.2019.10.008.
doi: 10.1016/j.jmii.2019.10.008
URL
pmid: 31926875
|
| [4] |
Flynn JL, Chan J, Lin PL. Macrophages and control of granulomatous inflammation in tuberculosis. Mucosal Immunol, 2011,4(3):271-278. doi: 10.1038/mi.2011.14.
doi: 10.1038/mi.2011.14
URL
pmid: 21430653
|
| [5] |
Ankrah AO, Glaudemans AWJM, Maes A, et al. Tuberculosis. Semin Nucl Med, 2018,48(2):108-130. doi: 10.1053/j.semnuclmed.2017.10.005.
doi: 10.1053/j.semnuclmed.2017.10.005
URL
pmid: 29452616
|
| [6] |
Ankrah AO, van der Werf TS, de Vries EF, et al. PET/CT imaging of Mycobacterium tuberculosis infection. Clin Transl Imaging, 2016,4:131-144. doi: 10.1007/s40336-016-0164-0.
doi: 10.1007/s40336-016-0164-0
URL
pmid: 27077068
|
| [7] |
Jamar F, Buscombe J, Chiti A, et al. EANM/SNMMI guideline for 18F-FDG use in inflammation and infection. J Nucl Med, 2013,54(4):647-658. doi: 10.2967/jnumed.112.112524.
URL
pmid: 23359660
|
| [8] |
Rodriguez-Takeuchi SY, Renjifo ME, Medina FJ. Extrapulmonary tuberculosis: pathophysiology and imaging findings. Radiographics, 2019,39(7):2023-2037. doi: 10.1148/rg.2019190109.
doi: 10.1148/rg.2019190109
URL
pmid: 31697616
|
| [9] |
Vorster M, Sathekge MM, Bomanji J. Advances in imaging of tuberculosis: the role of 18F-FDG PET and PET/CT. Curr Opin Pulm Med, 2014,20(3):287-293. doi: 10.1097/MCP.0000000000000043.
doi: 10.1097/MCP.0000000000000043
URL
pmid: 24614238
|
| [10] |
Coleman MT, Chen RY, Lee M, et al. PET/CT imaging reveals a therapeutic response to oxazolidinones in macaques and humans with tuberculosis. Sci Transl Med, 2014,6(265):265ra167. doi: 10.1126/scitranslmed.3009500.
doi: 10.1126/scitranslmed.3009500
URL
pmid: 25473035
|
| [11] |
Chopra A, Avadhani V, Tiwari A, et al. Granulomatous lung disease: clinical aspects. Expert Rev Respir Med, 2020,14(10):1045-1063. doi: 10.1080/17476348.2020.1794827.
doi: 10.1080/17476348.2020.1794827
URL
pmid: 32662705
|
| [12] |
中华医学会结核病学分会, 结核病病理学诊断专家共识编写组. 中国结核病病理学诊断专家共识. 中华结核和呼吸杂志, 2017,40(6):419-425. doi: 10.3760/cma.j.issn.1001-0939.2017.06.005.
|
| [13] |
Hu Y, Zhao X, Zhang J, et al. Value of 18F-FDG PET/CT radiomic features to distinguish solitary lung adenocarcinoma from tuberculosis. Eur J Nucl Med Mol Imaging, 2021,48(1):231-240. doi: 10.1007/s00259-020-04924-6.
URL
pmid: 32588088
|
| [14] |
Du D, Gu J, Chen X, et al. Integration of PET/CT radiomics and semantic features for differentiation between active pulmonary tuberculosis and lung cancer[J/OL]. Mol Imaging Biol, 2020[2020-10-24]. doi: 10.1007/s11307-020-01550-4.Online ahead of print.
|
京公网安备11010202007215号
Total visitors: Visitors of today: Now online:
This work is licensed under Creative Commons Attribution 3.0 License.
